Skip to Main Content

Author Details

Lionel Larue
Institut Curie, PSL Research University, INSERM U1021
1987
223
59
PMIDPaper TitleJournal TitlePublished Year
37739336Loss of Dicer in Newborn Melanocytes Leads to Premature Hair Graying and Changes in Integrin Expression.J Invest Dermatol2024
37739336Loss of Dicer in Newborn Melanocytes Leads to Premature Hair Graying and Changes in Integrin Expression.J Invest Dermatol2024
36958885Derivation and Use of Cell Lines from Mouse Models of Melanoma.J Invest Dermatol2023
37786677Novel mechanisms of MITF regulation and melanoma predisposition identified in a mouse suppressor screen.bioRxiv2023
36958885Derivation and Use of Cell Lines from Mouse Models of Melanoma.J Invest Dermatol2023
37786677Novel mechanisms of MITF regulation and melanoma predisposition identified in a mouse suppressor screen.bioRxiv2023
34310951CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3.J Invest Dermatol2022
36028184[How I do⿦ oocyte retrieval with locoregional anesthesia of parameters under vaginal ultrasound].Gynecol Obstet Fertil Senol2022
35505094Correction to: Thymine DNA glycosylase as a novel target for melanoma.Oncogene2022
34310951CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3.J Invest Dermatol2022
35288462ZEB1 transcription factor promotes immune escape in melanoma.J Immunother Cancer2022
35150661Adipocyte Extracellular Vesicles Decrease p16<sup>INK4A</sup> in Melanoma: An Additional Link between Obesity and Cancer.J Invest Dermatol2022
35158973Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.Cancers (Basel)2022
35505094Correction to: Thymine DNA glycosylase as a novel target for melanoma.Oncogene2022
36028184[How I do⿦ oocyte retrieval with locoregional anesthesia of parameters under vaginal ultrasound].Gynecol Obstet Fertil Senol2022
35158973Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.Cancers (Basel)2022
35288462ZEB1 transcription factor promotes immune escape in melanoma.J Immunother Cancer2022
35150661Adipocyte Extracellular Vesicles Decrease p16<sup>INK4A</sup> in Melanoma: An Additional Link between Obesity and Cancer.J Invest Dermatol2022
33091424Targeted Knockout of β-Catenin in Adult Melanocyte Stem Cells Using a Mouse Line, Dct::CreER<sup>T2</sup>, Results in Disrupted Stem Cell Renewal and Pigmentation Defects.J Invest Dermatol2021
33804655Efficacy of Targeted Radionuclide Therapy Using [<sup>131</sup>I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.Cancers (Basel)2021
34145395Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotype.Genet Med2021
33772156A role for Dynlt3 in melanosome movement, distribution, acidity and transfer.Commun Biol2021
34140478BRN2 is a non-canonical melanoma tumor-suppressor.Nat Commun2021
33438577MITF reprograms the extracellular matrix and focal adhesion in melanoma.Elife2021
33091424Targeted Knockout of β-Catenin in Adult Melanocyte Stem Cells Using a Mouse Line, Dct::CreER<sup>T2</sup>, Results in Disrupted Stem Cell Renewal and Pigmentation Defects.J Invest Dermatol2021
33323974STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.Oncogene2021
34604380Molecular Profiling of Spermatozoa Reveals Correlations between Morphology and Gene Expression: A Novel Biomarker Panel for Male Infertility.Biomed Res Int2021
34819350TBX2 controls a proproliferative gene expression program in melanoma.Genes Dev2021
33804655Efficacy of Targeted Radionuclide Therapy Using [<sup>131</sup>I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma.Cancers (Basel)2021
33772156A role for Dynlt3 in melanosome movement, distribution, acidity and transfer.Commun Biol2021
34819350TBX2 controls a proproliferative gene expression program in melanoma.Genes Dev2021
34604380Molecular Profiling of Spermatozoa Reveals Correlations between Morphology and Gene Expression: A Novel Biomarker Panel for Male Infertility.Biomed Res Int2021
34145395Inherited duplications of PPP2R3B predispose to nevi and melanoma via a C21orf91-driven proliferative phenotype.Genet Med2021
34140478BRN2 is a non-canonical melanoma tumor-suppressor.Nat Commun2021
33323974STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.Oncogene2021
33438577MITF reprograms the extracellular matrix and focal adhesion in melanoma.Elife2021
31065107Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.Cell Death Differ2020
31679174Sequencing two Tyr::CreER<sup>T2</sup> transgenic mouse lines.Pigment Cell Melanoma Res2020
32346747Melanoma Risk and Melanocyte Biology.Acta Derm Venereol2020
31806640Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma Progression.Cancer Res2020
34223272Evaluation of a strategy for difficult embryo transfers from a prospective series of 2,046 transfers.F S Rep2020
32881934MITF and TFEB cross-regulation in melanoma cells.PLoS One2020
31065107Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.Cell Death Differ2020
34223272Evaluation of a strategy for difficult embryo transfers from a prospective series of 2,046 transfers.F S Rep2020
31806640Netrin-1 and Its Receptor DCC Are Causally Implicated in Melanoma Progression.Cancer Res2020
31679174Sequencing two Tyr::CreER<sup>T2</sup> transgenic mouse lines.Pigment Cell Melanoma Res2020
32881934MITF and TFEB cross-regulation in melanoma cells.PLoS One2020
32346747Melanoma Risk and Melanocyte Biology.Acta Derm Venereol2020
30536790Molecular and cellular basis of depigmentation in vitiligo patients.Exp Dermatol2019
31740775Translational reprogramming marks adaptation to asparagine restriction in cancer.Nat Cell Biol2019
  • 1 - 50 of 446

Recommended Authors

National Cancer Institute, National Institutes of Health
Career Start Year 2010
Number of shared co-authors 9
Memorial Sloan Kettering Cancer Center
Career Start Year 2008
Number of shared co-authors 10
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 5
Harvard University
Career Start Year 2005
Number of shared co-authors 1
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 11
Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 3
Universite Paris Cite, CNRS
Career Start Year 2002
Number of shared co-authors 0
Max Planck Institute of Molecular Cell Biology and Genetics
Career Start Year 2001
Number of shared co-authors 1
1Rijnstate Hospital
Career Start Year 2001
Number of shared co-authors 0
Netherlands Cancer Institute
Career Start Year 2001
Number of shared co-authors 8
Princess Margaret Cancer Centre
Career Start Year 2001
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2000
Number of shared co-authors 0
Institute of Anatomy, University of Zurich
Career Start Year 1998
Number of shared co-authors 9
University of California Davis Health
Career Start Year 1995
Number of shared co-authors 3
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year 1994
Number of shared co-authors 1
University of Turin
Career Start Year 1991
Number of shared co-authors 0
Inc., Salk Institute for Biological Studies
Career Start Year 1989
Number of shared co-authors 0
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
University of Maryland School of Medicine
Career Start Year 1989
Number of shared co-authors 6
Children's Hospital of Los Angeles
Career Start Year 1988
Number of shared co-authors 3
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 1
The University of Queensland Diamantina Institute, The University of Queensland
Career Start Year 1985
Number of shared co-authors 2
Stanford University
Career Start Year 1985
Number of shared co-authors 0
Princess Maxima Center for Pediatric Oncology
Career Start Year 1985
Number of shared co-authors 3
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 16
Institute of Anatomy, University of Zurich
Career Start Year 1980
Number of shared co-authors 9
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 2
The Rockefeller University
Career Start Year 1976
Number of shared co-authors 6
National Cancer Institute
Career Start Year 1945
Number of shared co-authors 5

Collaborators

INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
Co-authored papers 19
Ludwig Institute for Cancer Research, University of Oxford
Co-authored papers 12
BioMedical Center, University of Iceland
Co-authored papers 10
Co-authored papers 6
The Institute of Cancer Research
Co-authored papers 5
Institut Curie, INSERM U1, PSL Research University
Co-authored papers 5
Biomedical Center, University of Iceland
Co-authored papers 5
University of Iowa
Co-authored papers 4
University of Iceland
Co-authored papers 4
Frazer Institute, The University of Queensland, Dermatology Research Centre
Co-authored papers 3
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
Co-authored papers 3
National Centre for Biotechnology (CNB-CSIC)
Co-authored papers 3
Yale School of Medicine
Co-authored papers 3
University of Illinois at Urbana-Champaign
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Institut Curie
Co-authored papers 2
Institut Curie
Co-authored papers 2
BioMedical Center, University of Iceland
Co-authored papers 2
Institut Curie
Co-authored papers 2
Fox Chase Cancer Center
Co-authored papers 2
Universite de Toulouse
Co-authored papers 2
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 2
Institut Curie, CNRS, PSL Research University
Co-authored papers 2
University of South Alabama
Co-authored papers 2
College of Dentistry & Dental Clinics, University of Iowa
Co-authored papers 2
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 2
Oncomark Ltd.
Co-authored papers 2
University of Iceland
Co-authored papers 2
Institute of Life and Environmental Sciences, University of Iceland
Co-authored papers 1